117 related articles for article (PubMed ID: 8167552)
21. Expression of low-, intermediate-, and high-affinity IL-2 receptors on B cell lines derived from patients with undifferentiated lymphoma of Burkitt's and non-Burkitt's types.
Benjamin D; Rosolen A; Wormsley SB; DeBault LE; Colamonici OR
Cell Immunol; 1990 Aug; 129(1):112-24. PubMed ID: 2364438
[TBL] [Abstract][Full Text] [Related]
22. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
24. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines.
Kube D; Platzer C; von Knethen A; Straub H; Bohlen H; Hafner M; Tesch H
Cytokine; 1995 Jan; 7(1):1-7. PubMed ID: 7749063
[TBL] [Abstract][Full Text] [Related]
25. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.
Hochberg D; Middeldorp JM; Catalina M; Sullivan JL; Luzuriaga K; Thorley-Lawson DA
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):239-44. PubMed ID: 14688409
[TBL] [Abstract][Full Text] [Related]
26. Differential effect of IL-4 and IL-13 on CD44 expression in the Burkitt's lymphoma B cell line BL30/B95-8 and in Epstein-Barr virus (EBV) transformed human B cells: loss of IL-13 receptors on Burkitt's lymphoma B cells.
Gee K; Kozlowski M; Kryworuchko M; Diaz-Mitoma F; Kumar A
Cell Immunol; 2001 Aug; 211(2):131-42. PubMed ID: 11591117
[TBL] [Abstract][Full Text] [Related]
27. [Epstein-Barr virus associated lymphocyte proliferation].
Stein H; Hummel M; Anagnostopoulos I; Korbjuhn P; Niedobitek G; Dallenbach F; Herbst H
Verh Dtsch Ges Pathol; 1992; 76():79-95. PubMed ID: 1283280
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10.
Burdin N; Péronne C; Banchereau J; Rousset F
J Exp Med; 1993 Feb; 177(2):295-304. PubMed ID: 8381152
[TBL] [Abstract][Full Text] [Related]
29. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
Menezes J; Leibold W; Klein G; Clements G
Biomedicine; 1975 Jul; 22(4):276-84. PubMed ID: 179629
[TBL] [Abstract][Full Text] [Related]
30. Human B-lymphoid cell lines.
Nilsson K
Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
[TBL] [Abstract][Full Text] [Related]
31. Interferon-gamma gene expression in human B-cell lines: induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation.
Pang Y; Norihisa Y; Benjamin D; Kantor RR; Young HA
Blood; 1992 Aug; 80(3):724-32. PubMed ID: 1322203
[TBL] [Abstract][Full Text] [Related]
32. Regulation of germ-line epsilon transcription and induction of epsilon switching in cloned EBV-transformed and malignant human B cell lines by cytokines and CD4+ T cells.
Gauchat JF; Gascan H; de Waal Malefyt R; de Vries JE
J Immunol; 1992 Apr; 148(7):2291-9. PubMed ID: 1347554
[TBL] [Abstract][Full Text] [Related]
33. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
34. [Cytokine-regulating activity of anti-virus preparation CelAgripus in Burkitt's lymphoma stable B-cell lines.].
Narovlyansky AN; Mezentseva MV; Suetina IA; Russu LI; Ivanova AM; Poloskov VV; Izmest'eva AV; Ospelnikova TP; Sarymsakov AA; Ershov FI
Vopr Virusol; 2019; 64(4):165-172. PubMed ID: 32163682
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.
Kennedy G; Komano J; Sugden B
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14269-74. PubMed ID: 14603034
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
[TBL] [Abstract][Full Text] [Related]
37. Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma.
Miyauchi K; Urano E; Yoshiyama H; Komano J
Cancer Sci; 2011 Jun; 102(6):1236-41. PubMed ID: 21392167
[TBL] [Abstract][Full Text] [Related]
38. The role of cytokines in the pathogenesis and management of AIDS-related lymphomas.
Fassone L; Gaidano G; Ariatti C; Vivenza D; Capello D; Gloghini A; Cilia AM; Buonaiuto D; Rossi D; Pastore C; Carbone A; Saglio G
Leuk Lymphoma; 2000 Aug; 38(5-6):481-8. PubMed ID: 10953968
[TBL] [Abstract][Full Text] [Related]
39. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
40. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
